These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 5791767)
1. [A simple method for the determination of the degree of fineness of tablet fragments after disintegration]. Sanders JC Pharm Weekbl; 1969 Jun; 104(24):485-92. PubMed ID: 5791767 [No Abstract] [Full Text] [Related]
2. The presence of microorganisms in some common excipients used in tablet formulation. Obuekwe IF; Eichie F Acta Pol Pharm; 2006; 63(2):121-5. PubMed ID: 17514875 [TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical controls for drug availability. Cook D Med Serv J Can; 1967 Mar; 23(3):323-36. PubMed ID: 6056376 [No Abstract] [Full Text] [Related]
4. The effect of the analytical error on content uniformity sampling plans. Norberg R Pharm Acta Helv; 1972; 47(11):710-8. PubMed ID: 4657537 [No Abstract] [Full Text] [Related]
5. Tablet splitting, education on NABP delegates' minds. Am J Health Syst Pharm; 2001 Aug; 58(15):1390, 1394. PubMed ID: 11494782 [No Abstract] [Full Text] [Related]
6. Tablet splitting: imperfect perhaps, but better than excessive dosing. Cohen JS J Am Pharm Assoc (Wash); 2002; 42(2):160-2. PubMed ID: 11926659 [No Abstract] [Full Text] [Related]
7. Panel discussion: in process control and inspection for quality assurance. 3. Brofazi FR Bull Parenter Drug Assoc; 1968; 22(2):90-6. PubMed ID: 5649572 [No Abstract] [Full Text] [Related]
8. Application of content uniformity test to tablet preparations. Kovács I; Hadady KK; Darbai MJ Pharmazie; 1980; 35(10):609-12. PubMed ID: 6779284 [TBL] [Abstract][Full Text] [Related]
9. Tablet splitting: much ado about nothing? Navarro RP J Manag Care Pharm; 2009 Apr; 15(3):272-4. PubMed ID: 19326958 [No Abstract] [Full Text] [Related]
10. Influence of compression forces on tablets disintegration by AC Biosusceptometry. Corá LA; Fonseca PR; Américo MF; Oliveira RB; Baffa O; Miranda JR Eur J Pharm Biopharm; 2008 May; 69(1):372-9. PubMed ID: 18164605 [TBL] [Abstract][Full Text] [Related]
11. [Technologic control of tablet coatings]. Dia S; Guyot JC; Traisnel M J Pharm Belg; 1973; 28(6):663-80. PubMed ID: 4774837 [No Abstract] [Full Text] [Related]
12. Weight variability of pharmacist-dispensed split tablets. Rosenberg JM; Nathan JP; Plakogiannis F J Am Pharm Assoc (Wash); 2002; 42(2):200-5. PubMed ID: 11926663 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets. Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the content uniformity plan. Sampson CB; Breunig HL; Comer JP; Broadlick DE J Pharm Sci; 1970 Nov; 59(11):1653-5. PubMed ID: 5495497 [No Abstract] [Full Text] [Related]
16. [The use of tween-80 for the improvement of tablet disintegration]. Borzunov EE; Shevchenko SM; Nosovitskaia SA Med Prom SSSR; 1965 Nov; 19(11):31-4. PubMed ID: 5212258 [No Abstract] [Full Text] [Related]